CompletedPhase 2NCT00835224
Safety and Efficacy of L-NAME and Midodrine to Increase MAP
Studying Rare autonomic nervous system disorder
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- US Department of Veterans Affairs
- Principal Investigator
- Jill Wecht, EdDVA Medical Center, Bronx
- Intervention
- L-NAME(drug)
- Enrollment
- 34 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2010 – 2013
Study locations (1)
- VA Medical Center, Bronx, The Bronx, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00835224 on ClinicalTrials.govOther trials for Rare autonomic nervous system disorder
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07089043A Study in Subjects With Neurogenic Orthostatic HypotensionCuraSen Therapeutics, Inc.
- RECRUITINGNANCT06841198Cardiovascular Function and Response to Stimulation Within the First Year After Spinal Cord InjuryKessler Foundation
- RECRUITINGNANCT06694688Evaluation of the Contribution of Lower Limb and/or Abdominal Compression on Orthostatic HypotensionGérond'if
- RECRUITINGNANCT07195903The STAND-UP StudySt. Francis Hospital, New York
- RECRUITINGNANCT06587841Noninvasive Spinal Cord Stimulation for Early SCIUniversity of British Columbia
- RECRUITINGPHASE2NCT06188663SalT Supplementation in Older Adults With Orthostatic Intolerance DisordersUniversity of Galway
- RECRUITINGNANCT05908760CO2 Rebreathing in nOH: A Proof-of-Concept Pilot StudyUniversity of Calgary
- ACTIVE NOT RECRUITINGNCT06439498Frequency of Orthostatic Hypotension in Patients Who Underwent ColonoscopyAnkara University